Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Gattenlöhner S[au]:

Search results

Items: 1 to 50 of 151

1.

Molecular Targeting Therapy against EGFR Family in Breast Cancer: Progress and Future Potentials.

Maennling AE, Tur MK, Niebert M, Klockenbring T, Zeppernick F, Gattenlöhner S, Meinhold-Heerlein I, Hussain AF.

Cancers (Basel). 2019 Nov 20;11(12). pii: E1826. doi: 10.3390/cancers11121826. Review.

2.

IRE1 Signaling As a Putative Therapeutic Target in Influenza Virus-induced Pneumonia.

Schmoldt C, Vazquez-Armendariz AI, Shalashova I, Selvakumar B, Bremer CM, Peteranderl C, Wasnick R, Witte B, Gattenlöhner S, Fink L, Vadász I, Morty RE, Pleschka S, Seeger W, Günther A, Herold S.

Am J Respir Cell Mol Biol. 2019 Oct;61(4):537-540. doi: 10.1165/rcmb.2019-0123LE. No abstract available.

PMID:
31573336
3.

Elimination of HER3-expressing breast cancer cells using aptamer-siRNA chimeras.

Nachreiner I, Hussain AF, Wullner U, Machuy N, Meyer TF, Fischer R, Gattenlöhner S, Meinhold-Heerlein I, Barth S, Tur MK.

Exp Ther Med. 2019 Oct;18(4):2401-2412. doi: 10.3892/etm.2019.7753. Epub 2019 Jul 9.

4.

Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responses.

Timofeev O, Klimovich B, Schneikert J, Wanzel M, Pavlakis E, Noll J, Mutlu S, Elmshäuser S, Nist A, Mernberger M, Lamp B, Wenig U, Brobeil A, Gattenlöhner S, Köhler K, Stiewe T.

EMBO J. 2019 Oct 15;38(20):e102096. doi: 10.15252/embj.2019102096. Epub 2019 Sep 4.

5.

Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma.

Desch AK, Hartung K, Botzen A, Brobeil A, Rummel M, Kurch L, Georgi T, Jox T, Bielack S, Burdach S, Classen CF, Claviez A, Debatin KM, Ebinger M, Eggert A, Faber J, Flotho C, Frühwald M, Graf N, Jorch N, Kontny U, Kramm C, Kulozik A, Kühr J, Sykora KW, Metzler M, Müller HL, Nathrath M, Nüßlein T, Paulussen M, Pekrun A, Reinhardt D, Reinhard H, Rössig C, Sauerbrey A, Schlegel PG, Schneider DT, Scheurlen W, Schweigerer L, Simon T, Suttorp M, Vorwerk P, Schmitz R, Kluge R, Mauz-Körholz C, Körholz D, Gattenlöhner S, Bräuninger A.

Leukemia. 2020 Jan;34(1):151-166. doi: 10.1038/s41375-019-0541-6. Epub 2019 Aug 20.

PMID:
31431735
6.

Impact on survival of tobacco smoking for cases with oropharyngeal squamous cell carcinoma and known human papillomavirus and p16-status: a multicenter retrospective study.

Grønhøj C, Jensen JS, Wagner S, Dehlendorff C, Friborg J, Andersen E, Wittekindt C, Würdemann N, Sharma SJ, Gattenlöhner S, Klussmann JP, von Buchwald C.

Oncotarget. 2019 Jul 23;10(45):4655-4663. doi: 10.18632/oncotarget.27079. eCollection 2019 Jul 23.

7.

Nuclear factor of activated T-cells, NFATC1, governs FLT3ITD-driven hematopoietic stem cell transformation and a poor prognosis in AML.

Solovey M, Wang Y, Michel C, Metzeler KH, Herold T, Göthert JR, Ellenrieder V, Hessmann E, Gattenlöhner S, Neubauer A, Pavlinic D, Benes V, Rupp O, Burchert A.

J Hematol Oncol. 2019 Jul 8;12(1):72. doi: 10.1186/s13045-019-0765-y.

8.

Crosstalks of the PTPIP51 interactome revealed in Her2 amplified breast cancer cells by the novel small molecule LDC3/Dynarrestin.

Dietel E, Brobeil A, Delventhal L, Tag C, Gattenlöhner S, Wimmer M.

PLoS One. 2019 May 10;14(5):e0216642. doi: 10.1371/journal.pone.0216642. eCollection 2019.

9.

Aneuploidy in children with relapsed B-cell precursor acute lymphoblastic leukaemia: clinical importance of detecting a hypodiploid origin of relapse.

Groeneveld-Krentz S, Schroeder MP, Reiter M, Pogodzinski MJ, Pimentel-Gutiérrez HJ, Vagkopoulou R, Hof J, Chen-Santel C, Nebral K, Bradtke J, Türkmen S, Baldus CD, Gattenlöhner S, Haas OA, von Stackelberg A, Karawajew L, Eckert C, Kirschner-Schwabe R.

Br J Haematol. 2019 Apr;185(2):266-283. doi: 10.1111/bjh.15770. Epub 2019 Feb 3.

PMID:
30714092
10.

aPKC controls endothelial growth by modulating c-Myc via FoxO1 DNA-binding ability.

Riddell M, Nakayama A, Hikita T, Mirzapourshafiyi F, Kawamura T, Pasha A, Li M, Masuzawa M, Looso M, Steinbacher T, Ebnet K, Potente M, Hirose T, Ohno S, Fleming I, Gattenlöhner S, Aung PP, Phung T, Yamasaki O, Yanagi T, Umemura H, Nakayama M.

Nat Commun. 2018 Dec 17;9(1):5357. doi: 10.1038/s41467-018-07739-0.

11.

Only strongly enhanced residual FDG uptake in early response PET (Deauville 5 or qPET ≥ 2) is prognostic in pediatric Hodgkin lymphoma: Results of the GPOH-HD2002 trial.

Kurch L, Hasenclever D, Kluge R, Georgi T, Tchavdarova L, Golombeck M, Sabri O, Eggert A, Brenner W, Sykora KW, Bengel FM, Rossig C, Körholz D, Schäfers M, Feuchtinger T, Bartenstein P, Ammann RA, Krause T, Urban C, Aigner R, Gattenlöhner S, Klapper W, Mauz-Körholz C.

Pediatr Blood Cancer. 2019 Mar;66(3):e27539. doi: 10.1002/pbc.27539. Epub 2018 Nov 14.

PMID:
30426671
12.

The Importance of the Right Framework: Mitogen-Activated Protein Kinase Pathway and the Scaffolding Protein PTPIP51.

Dietel E, Brobeil A, Gattenlöhner S, Wimmer M.

Int J Mol Sci. 2018 Oct 22;19(10). pii: E3282. doi: 10.3390/ijms19103282. Review.

13.

Myocardial Fibrosis Predicts 10-Year Survival in Patients Undergoing Aortic Valve Replacement.

Herrmann S, Fries B, Salinger T, Liu D, Hu K, Gensler D, Strotmann J, Christa M, Beer M, Gattenlöhner S, Störk S, Voelker W, Bening C, Lorenz K, Leyh R, Frantz S, Ertl G, Weidemann F, Nordbeck P.

Circ Cardiovasc Imaging. 2018 Aug;11(8):e007131. doi: 10.1161/CIRCIMAGING.117.007131.

PMID:
30354492
14.

Response to 'Aberrant expression of TdT in seminomatous germ cell neoplasia'.

Brobeil A, Wagenlehner F, Gattenlöhner S.

Virchows Arch. 2018 Sep;473(3):387. doi: 10.1007/s00428-018-2403-4. Epub 2018 Jul 6. No abstract available.

PMID:
29980856
15.

Development and external validation of nomograms in oropharyngeal cancer patients with known HPV-DNA status: a European Multicentre Study (OroGrams).

Grønhøj C, Jensen DH, Dehlendorff C, Marklund L, Wagner S, Mehanna H, Munck-Wikland E, Ramqvist T, Näsman A, Wittekindt C, Würdemann N, Sharma SJ, Gattenlöhner S, Kiss K, Andersen E, Spruce R, Batis N, Robinson M, Harrington K, Winter S, Jones TM, Klussmann JP, Dalianis T, Friborg J, von Buchwald C.

Br J Cancer. 2018 Jun;118(12):1672-1681. doi: 10.1038/s41416-018-0107-9. Epub 2018 May 24.

16.

Combined human papillomavirus typing and TP53 mutation analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma.

Daher T, Tur MK, Brobeil A, Etschmann B, Witte B, Engenhart-Cabillic R, Krombach G, Blau W, Grimminger F, Seeger W, Klussmann JP, Bräuninger A, Gattenlöhner S.

Head Neck. 2018 Jun;40(6):1109-1119. doi: 10.1002/hed.25041. Epub 2018 Mar 9.

PMID:
29522268
17.

Targeted Next-Generation Sequencing Is a Sensitive Tool for Differential Diagnosis of Myelodysplastic Syndromes in Bone Marrow Trephines.

Bräuninger A, Blau W, Kunze K, Desch AK, Brobeil A, Tur MK, Etschmann B, Günther U, Körholz D, Schliesser G, Käbisch A, Kiehl M, Rummel M, Gattenlöhner S.

J Mol Diagn. 2018 May;20(3):344-354. doi: 10.1016/j.jmoldx.2018.01.006. Epub 2018 Feb 19.

18.

[The innate immune system in oropharyngeal squamous cell carcinoma : Immune modulation by HPV].

Wagner S, Böckmann H, Gattenlöhner S, Klussmann JP, Wittekindt C.

HNO. 2018 Apr;66(4):301-307. doi: 10.1007/s00106-018-0480-y. Review. German.

PMID:
29468275
19.

Expression of terminal deoxynucleotidyl transferase (TdT) in classical seminoma: a potential diagnostic pitfall.

Brobeil A, Wagenlehner F, Gattenlöhner S.

Virchows Arch. 2018 Mar;472(3):433-440. doi: 10.1007/s00428-018-2313-5. Epub 2018 Feb 18.

PMID:
29455318
20.

Similar Characteristics of Endometrial and Endometriotic Epithelial Cells.

Konrad L, Gronbach J, Horné F, Mecha EO, Berkes E, Frank M, Gattenlöhner S, Omwandho COA, Oehmke F, Tinneberg HR.

Reprod Sci. 2019 Jan;26(1):49-59. doi: 10.1177/1933719118756745. Epub 2018 Feb 5.

PMID:
29402201
21.

Reply to 'Comment on 'Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer".

Wagner S, Wittekindt C, Sharma SJ, Wuerdemann N, Jüttner T, Reuschenbach M, Prigge ES, von Knebel Doeberitz M, Gattenlöhner S, Burkhardt E, Pons-Kühnemann J, Klussmann JP.

Br J Cancer. 2018 Feb 6;118(3):e6. doi: 10.1038/bjc.2017.464. Epub 2018 Jan 23. No abstract available.

22.

Lung cancer-associated pulmonary hypertension: Role of microenvironmental inflammation based on tumor cell-immune cell cross-talk.

Pullamsetti SS, Kojonazarov B, Storn S, Gall H, Salazar Y, Wolf J, Weigert A, El-Nikhely N, Ghofrani HA, Krombach GA, Fink L, Gattenlöhner S, Rapp UR, Schermuly RT, Grimminger F, Seeger W, Savai R.

Sci Transl Med. 2017 Nov 15;9(416). pii: eaai9048. doi: 10.1126/scitranslmed.aai9048.

PMID:
29141888
23.

Antibody Selection on FFPE Tissue Slides.

Ten Haaf A, Gattenlöhner S, Tur MK.

Methods Mol Biol. 2018;1701:381-391. doi: 10.1007/978-1-4939-7447-4_21.

PMID:
29116517
24.

Restoration of DAP Kinase Tumor Suppressor Function: A Therapeutic Strategy to Selectively Induce Apoptosis in Cancer Cells Using Immunokinase Fusion Proteins.

Tur MK, Daramola AK, Gattenlöhner S, Herling M, Chetty S, Barth S.

Biomedicines. 2017 Oct 4;5(4). pii: E59. doi: 10.3390/biomedicines5040059. Review.

25.

Hepatitis B virus surface proteins accelerate cholestatic injury and tumor progression in Abcb4-knockout mice.

Zahner D, Glimm H, Matono T, Churin Y, Herebian D, Mayatepek E, Köhler K, Gattenlöhner S, Stinn A, Tschuschner A, Roderfeld M, Roeb E.

Oncotarget. 2017 Feb 2;8(32):52560-52570. doi: 10.18632/oncotarget.15003. eCollection 2017 Aug 8.

26.

The role of high-risk human papillomavirus infections in laryngeal squamous cell carcinoma.

Wittekindt C, Wuerdemann N, Gattenlöhner S, Brobeil A, Wierzbicka M, Wagner S, Klußmann JP.

Eur Arch Otorhinolaryngol. 2017 Nov;274(11):3837-3842. doi: 10.1007/s00405-017-4718-1. Epub 2017 Aug 31. Review.

PMID:
28861601
27.

[Fibrinous lesions of the larynx in a 34-year old patient].

Wuerdemann N, Sharma SJ, Gattenlöhner S, Klußmann JP, Wittekindt C.

Laryngorhinootologie. 2017 Oct;96(10):710-713. doi: 10.1055/s-0043-116664. Epub 2017 Aug 23. German. No abstract available.

PMID:
28834976
28.

Altered Protein Interactions of the Endogenous Interactome of PTPIP51 towards MAPK Signaling.

Brobeil A, Chehab R, Dietel E, Gattenlöhner S, Wimmer M.

Biomolecules. 2017 Jul 21;7(3). pii: E55. doi: 10.3390/biom7030055.

29.

[Disseminated osteolytic lesions in a 28-year-old refugee].

Karrasch T, Walmrath HD, Kampschulte M, Steiner D, Seeger W, Padberg W, Sibelius U, Gattenlöhner S, Schäffler A.

Internist (Berl). 2018 May;59(5):486-493. doi: 10.1007/s00108-017-0300-6. German.

PMID:
28748250
30.

Prognostic Impact of AJCC/UICC 8th Edition New Staging Rules in Oropharyngeal Squamous Cell Carcinoma.

Würdemann N, Wagner S, Sharma SJ, Prigge ES, Reuschenbach M, Gattenlöhner S, Klussmann JP, Wittekindt C.

Front Oncol. 2017 Jun 30;7:129. doi: 10.3389/fonc.2017.00129. eCollection 2017.

31.

Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancer.

Kessler C, Pardo A, Tur MK, Gattenlöhner S, Fischer R, Kolberg K, Barth S.

J Cancer Res Clin Oncol. 2017 Oct;143(10):2025-2038. doi: 10.1007/s00432-017-2472-9. Epub 2017 Jun 30.

PMID:
28667390
32.

Risk Factors for Overall Survival Outcome in Surgically Treated Human Papillomavirus-Negative and Positive Patients with Oropharyngeal Cancer.

Wuerdemann N, Wittekindt C, Sharma SJ, Prigge ES, Reuschenbach M, Gattenlöhner S, Klussmann JP, Wagner S.

Oncol Res Treat. 2017;40(6):320-327. doi: 10.1159/000477097. Epub 2017 May 17.

PMID:
28558385
33.

Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer.

Wagner S, Wittekindt C, Sharma SJ, Wuerdemann N, Jüttner T, Reuschenbach M, Prigge ES, von Knebel Doeberitz M, Gattenlöhner S, Burkhardt E, Pons-Kühnemann J, Klussmann JP.

Br J Cancer. 2017 Jun 6;116(12):1604-1611. doi: 10.1038/bjc.2017.132. Epub 2017 May 4.

34.

Development of a monoclonal sandwich ELISA for direct detection of bluetongue virus 8 in infected animals.

Ten Haaf A, Kohl J, Pscherer S, Hamann HP, Eskens HU, Bastian M, Gattenlöhner S, Tur MK.

J Virol Methods. 2017 May;243:172-176. doi: 10.1016/j.jviromet.2017.02.003. Epub 2017 Feb 11.

PMID:
28193493
35.

Non-invasive lung cancer diagnosis by detection of GATA6 and NKX2-1 isoforms in exhaled breath condensate.

Mehta A, Cordero J, Dobersch S, Romero-Olmedo AJ, Savai R, Bodner J, Chao CM, Fink L, Guzmán-Díaz E, Singh I, Dobreva G, Rapp UR, Günther S, Ilinskaya ON, Bellusci S, Dammann RH, Braun T, Seeger W, Gattenlöhner S, Tresch A, Günther A, Barreto G.

EMBO Mol Med. 2016 Dec 1;8(12):1380-1389. doi: 10.15252/emmm.201606382. Print 2016 Dec.

36.

Orchestrating cellular signaling pathways-the cellular "conductor" protein tyrosine phosphatase interacting protein 51 (PTPIP51).

Brobeil A, Dietel E, Gattenlöhner S, Wimmer M.

Cell Tissue Res. 2017 Jun;368(3):411-423. doi: 10.1007/s00441-016-2508-5. Epub 2016 Oct 12. Review.

PMID:
27734150
37.

Matrix metalloproteinase-13 refines pathological staging of precancerous colorectal lesions.

Wernicke AK, Churin Y, Sheridan D, Windhorst A, Tschuschner A, Gattenlöhner S, Roderfeld M, Roeb E.

Oncotarget. 2016 Nov 8;7(45):73552-73557. doi: 10.18632/oncotarget.12429.

38.

Lévy Flights due to Anisotropic Disorder in Graphene.

Gattenlöhner S, Gornyi IV, Ostrovsky PM, Trauzettel B, Mirlin AD, Titov M.

Phys Rev Lett. 2016 Jul 22;117(4):046603. doi: 10.1103/PhysRevLett.117.046603. Epub 2016 Jul 22.

PMID:
27494489
39.

Unusual gastric mucosal infiltration by a medullary thyroid carcinoma: a case report.

Karrasch T, Doppl W, Roller FC, Schäffler A, Schäffer R, Gattenlöhner S.

J Med Case Rep. 2016 Jul 27;10:208. doi: 10.1186/s13256-016-0981-9.

40.

Correction: Macrophage-expressed IFN-β Contributes to Apoptotic Alveolar Epithelial Cell Injury in Severe Influenza Virus Pneumonia.

Högner K, Wolff T, Pleschka S, Plog S, Gruber AD, Kalinke U, Walmrath HD, Bodner J, Gattenlöhner S, Lewe-Schlosser P, Matrosovich M, Seeger W, Lohmeyer J, Herold S.

PLoS Pathog. 2016 Jun 15;12(6):e1005716. doi: 10.1371/journal.ppat.1005716. eCollection 2016 Jun.

41.

FGFR1 amplification and co-overexpression of c-MYC in oropharyngeal squamous cell carcinoma.

Ozretić L, Wagner S, Huebbers CU, Gattenlöhner S, Klussmann JP, Beutner D, Zander T, Buettner R, Quaas A.

Oral Oncol. 2016 Mar;54:e7-9. doi: 10.1016/j.oraloncology.2015.12.006. Epub 2016 Jan 8. No abstract available.

PMID:
26778475
42.

CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma.

Wagner S, Wittekindt C, Reuschenbach M, Hennig B, Thevarajah M, Würdemann N, Prigge ES, von Knebel Doeberitz M, Dreyer T, Gattenlöhner S, Klussmann JP.

Int J Cancer. 2016 May 1;138(9):2263-73. doi: 10.1002/ijc.29962. Epub 2016 Jan 8.

43.

[Pre-auricular mass in a 38-year-old patient].

Wuerdemann N, Sharma SJ, Kroll T, Streckbein P, Dreyer T, Gattenlöhner S, Wittekindt C, Klußmann JP.

Laryngorhinootologie. 2015 Dec;94(12):843-5. doi: 10.1055/s-0035-1559691. Epub 2015 Oct 15. German. No abstract available.

PMID:
26468671
44.

[77-year-old female with hyponatremia, pruritus and papulous exanthema].

Brock J, Karrasch T, Roller FC, Steiner D, Nilles M, Blau W, Gattenlöhner S, Schäffler A.

Dtsch Med Wochenschr. 2015 Jun;140(13):997-1000. doi: 10.1055/s-0041-102667. Epub 2015 Jun 26. German. Erratum in: Dtsch Med Wochenschr. 2015 Jul;140(15):1118. Roller, Ferdinand Fritz [corrected to Roller, Fritz Christian].

PMID:
26115135
45.

Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations.

Aukema SM, Theil L, Rohde M, Bauer B, Bradtke J, Burkhardt B, Bonn BR, Claviez A, Gattenlöhner S, Makarova O, Nagel I, Oschlies I, Pott C, Szczepanowski M, Traulsen A, Kluin PM, Klapper W, Siebert R, Murga Penas EM.

Br J Haematol. 2015 Sep;170(6):814-25. doi: 10.1111/bjh.13501. Epub 2015 Jun 24.

PMID:
26104998
46.

Phage display-based on-slide selection of tumor-specific antibodies on formalin-fixed paraffin-embedded human tissue biopsies.

Ten Haaf A, Pscherer S, Fries K, Barth S, Gattenlöhner S, Tur MK.

Immunol Lett. 2015 Aug;166(2):65-78. doi: 10.1016/j.imlet.2015.05.013. Epub 2015 Jun 2.

PMID:
26045318
47.

NFATc1 as a therapeutic target in FLT3-ITD-positive AML.

Metzelder SK, Michel C, von Bonin M, Rehberger M, Hessmann E, Inselmann S, Solovey M, Wang Y, Sohlbach K, Brendel C, Stiewe T, Charles J, Ten Haaf A, Ellenrieder V, Neubauer A, Gattenlöhner S, Bornhäuser M, Burchert A.

Leukemia. 2015 Jul;29(7):1470-7. doi: 10.1038/leu.2015.95. Epub 2015 Apr 14.

PMID:
25976987
48.

[Epithelial neuroendocrine tumors of the upper respiratory tract: New entities, new perspectives].

Brobeil A, Dreyer T, Schäffer R, Bräuninger A, Gattenlöhner S.

Pathologe. 2015 May;36(3):271-7. doi: 10.1007/s00292-015-0031-1. Review. German.

PMID:
25963713
49.

PTPIP51—A New RelA-tionship with the NFκB Signaling Pathway.

Brobeil A, Kämmerer F, Tag C, Steger K, Gattenlöhner S, Wimmer M.

Biomolecules. 2015 Apr 16;5(2):485-504. doi: 10.3390/biom5020485.

50.

Noninvasive fetal genotyping of human platelet antigen-1a using targeted massively parallel sequencing.

Wienzek-Lischka S, Krautwurst A, Fröhner V, Hackstein H, Gattenlöhner S, Bräuninger A, Axt-Fliedner R, Degenhardt J, Deisting C, Santoso S, Sachs UJ, Bein G.

Transfusion. 2015 Jun;55(6 Pt 2):1538-44. doi: 10.1111/trf.13102. Epub 2015 Apr 15.

PMID:
25873286

Supplemental Content

Loading ...
Support Center